What sets the FDA apart on medtech innovation? An expert weighs in

UCLA Biodesign executive director Dr. Jennifer McCaney shares insights on a recent research project with BCG examining the global regulatory landscape, and discusses what excites her about the industry's future.

Related Keywords

Boston ,Massachusetts ,United States ,Canada ,Kat Jercich ,Jennifer Mccaney ,Centers For Medicare ,Digital Health Center ,Boston Consulting Group ,Drug Administration ,Health Canada ,Medicaid Services ,Health Center ,Good Machine Learning Practice ,Medical Device ,